Publications by authors named "Prantesh Jain"

Claim this Profile
A
AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study.
Mohammadhadi Khorrami, Pushkar Mutha, Cristian Barrera, Vidya S Viswanathan, Fatemeh Ardeshir-Larijani, Prantesh Jain

Cancer Lett· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancancer outcome prediction via a unified weakly supervised deep learning model.
Wei Yuan, Yijiang Chen, Biyue Zhu, Sen Yang, Jiayu Zhang, Prantesh Jain

Signal Transduct Target Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin.
Randall J Smith, Robert Zollo, Sukumar Kalvapudi, Yeshwanth Vedire, Akhil Goud Pachimatla, Prantesh Jain

J Natl Cancer Inst· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.
Alfredo V Chua, Jennifer Delmerico, Haiyang Sheng, Xin-Wei Huang, Emily Liang, Prantesh Jain

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin.
Sarbajit Mukherjee, Harsha Pattnaik, Sahithi Sonti, Mrinalini Ramesh, Prantesh Jain

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi, Michael Jain, Prantesh Jain

J Natl Compr Canc Netw· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
Muhammad Awidi, Angel Mier-Hicks, Stuthi Perimbeti, Kristopher Attwood, Hongbin Chen, Prantesh Jain

Clin Lung Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
Joseph Elijah, Prantesh Jain, Allison Holdsworth, Jeffrey Baron, Eugene Przespolewski

Support Care Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
Sherry-Ann Brown, Craig Beavers, Brenton Bauer, Richard K Cheng, Generika Berman, Prantesh Jain

Am Heart J Plus· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.
Nathaniel Braman, Prateek Prasanna, Kaustav Bera, Mehdi Alilou, Mohammadhadi Khorrami, Prantesh Jain

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.
Prantesh Jain, Mohammadhadi Khorrami, Amit Gupta, Prabhakar Rajiah, Kaustav Bera

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation.
Avirup Guha, Cesar Caraballo, Prantesh Jain, P Elliott Miller, Jocelyn Owusu-Guha

ESC Heart Fail· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasopharyngeal neuroendocrine neoplasms: Systematic review of the literature and case presentation.
Jain Prantesh, Jennifer Dorth, Sylvia L Asa, Amr Mohamed

J Neuroendocrinol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registries.
Avirup Guha, Prantesh Jain, Michael G Fradley, Daniel Lenihan, Jahir M Gutierrez, Chhavi Jain

Cancer Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies.
Matthew Lee, Prantesh Jain, Feng Wang, Patrick C Ma, Alain Borczuk

Expert Opin Ther Targets· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis.
Avirup Guha, Daniel Addison, Prantesh Jain, Jahir M Gutierrez, Arjun Ghosh

Biol Blood Marrow Transplant· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.
Pranjal Vaidya, Kaustav Bera, Pradnya D Patil, Amit Gupta, Prantesh Jain

J Immunother Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between myocarditis and other immune-related adverse events secondary to immune checkpoint inhibitor use.
Avirup Guha, Sadeer Al-Kindi, Prantesh Jain, Nour Tashtish, Chantal ElAmm

Int J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
Eli Stahl, Giulia Roda, Amanda Dobbyn, Jianzhong Hu, Zhongyang Zhang, Prantesh Jain

Gastroenterology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features" [Lung Cancer 135 (September) (2019) 1-9].
Mohammadhadi Khorrami, Prantesh Jain, Kaustav Bera, Mehdi Alilou, Rajat Thawani

Lung Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
Mohammadhadi Khorrami, Prantesh Jain, Kaustav Bera, Mehdi Alilou, Rajat Thawani

Lung Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting.
Girish Kunapareddy, Benjamin Switzer, Prantesh Jain, Madison Conces, Yu-Wei Chen

Res Pract Thromb Haemost· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of immune-checkpoint inhibitors in lung cancer.
Prantesh Jain, Chhavi Jain, Vamsidhar Velcheti

Ther Adv Respir Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Monica Khunger, Prantesh Jain, Sagar Rakshit, Vinay Pasupuleti, Adrian V Hernandez

Clin Lung Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer with brain metastases in pregnancy.
Shweta Gupta, Prantesh Jain, Susan McDunn

J Community Support Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis